Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-23-009337
Filing Date
2023-03-23
Accepted
2023-03-23 08:57:09
Documents
5
Effectiveness Date
2023-03-23

Document Format Files

Seq Description Document Type Size
1 S-8 labp_s-8_3.23.23.htm S-8 159504
2 EX-5.1 labp-ex5_1.htm EX-5 23076
3 EX-23.1 labp-ex23_1.htm EX-23 5020
4 EX-FILING FEES labp-exfiling_fees.htm EX-FILING FEES 28246
5 GRAPHIC img155935805_0.jpg GRAPHIC 29364
  Complete submission text file 0000950170-23-009337.txt   257403
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Filer) CIK: 0001785345 (see all company filings)

EIN.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270768 | Film No.: 23754608
SIC: 2834 Pharmaceutical Preparations